Expert Perspectives on Biosimilar Agents

In this video module, a multidisciplinary panel of expert faculty discuss the use of biosimilars across oncology, rheumatology, dermatology, and gastroenterology specialties.

Andrew M. Evens, DO, MSc, FACP Jonathan Kay, MD Alan C. Moss, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: November 16, 2017 Expired: No longer available for credit

Part 1: Fundamentals (48 mins)

Part 2: Inflammatory Diseases (12 mins)

Part 3: Oncology (11 mins)

Part 4: Challenges (5 mins)

In these downloadable slides, a multidisciplinary panel of expert faculty discuss the use of biosimilars across oncology, rheumatology, dermatology, and gastroenterology specialties.

Multiple biosimilars are now approved for the treatment of active cancers. Here’s what oncologists need to know.

Hope S. Rugo, MD Released: January 18, 2018